SeaStar Medical (NASDAQ:ICU – Get Free Report) is one of 232 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it contrast to its peers? We will compare SeaStar Medical to related businesses based on the strength of its earnings, valuation, risk, dividends, profitability, institutional ownership and analyst recommendations.
Risk & Volatility
SeaStar Medical has a beta of -0.96, suggesting that its stock price is 196% less volatile than the S&P 500. Comparatively, SeaStar Medical’s peers have a beta of 1.07, suggesting that their average stock price is 7% more volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent ratings for SeaStar Medical and its peers, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
SeaStar Medical | 0 | 0 | 0 | 0 | N/A |
SeaStar Medical Competitors | 1603 | 4333 | 8507 | 223 | 2.50 |
Profitability
This table compares SeaStar Medical and its peers’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
SeaStar Medical | N/A | N/A | -741.57% |
SeaStar Medical Competitors | -737.35% | -146.92% | -29.30% |
Insider and Institutional Ownership
1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 48.2% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 4.5% of SeaStar Medical shares are owned by insiders. Comparatively, 15.4% of shares of all “Surgical & medical instruments” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Earnings & Valuation
This table compares SeaStar Medical and its peers revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
SeaStar Medical | N/A | -$26.23 million | -0.37 |
SeaStar Medical Competitors | $1.04 billion | $4.09 million | 1.54 |
SeaStar Medical’s peers have higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Summary
SeaStar Medical peers beat SeaStar Medical on 8 of the 10 factors compared.
About SeaStar Medical
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.